Article Text
Letter
A polymorphism in the gene encoding the Fcγ IIIA receptor is a possible genetic marker to predict the primary response to infliximab in Japanese patients with rheumatoid arthritis
Statistics from Altmetric.com
Footnotes
Competing interests: None.
Funding: Supported by grants provided by the Japan Orthopaedics and Traumatology Foundation (KI), Takeda Science Foundation (KI), and the Japanese Ministry of Education, Culture, Sports, Science and Technology (KI, ST)